BEVESPI AEROSPHERE® (glycopyrrolate/ formoterol fumarate) dosing BEVESPI AEROSPHERE® (glycopyrrolate/ formoterol fumarate) dosing
  • BEVESPI AEROSPHERE is NOT a rescue medication and does NOT replace fast-acting inhalers to treat acute symptoms

  • Do not use in combination with an additional medicine containing a LABA because of risk of overdose1

pMDI Device*…

  • Most commonly used inhaler in the US2†

  • Lower inspiratory flow requirement than a DPI3

  • Can be used with or without a spacer4

*The actual amount of a drug delivered to the lung may depend on patient factors, such as the coordination between actuation of the device and inspiration through the delivery system.1

More than three-quarters of patients with COPD in the US filled a prescription for a pMDI medication (March 2016-February 2017).2